Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Omadacycline was tested against 21,000 bacterial isolates collected prospectively from medical centers in Europe and the United States during 2016. Omadacycline was active against Staphylococcus aureus (MIC(50)/MIC(90), 0.12/0.25 mg/liter), including methicillin-resistant S. aureus (MRSA); streptoco...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Pfaller, Michael A., Huband, Michael D., Shortridge, Dee, Flamm, Robert K.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2018
Témata:
Epidemiology and Surveillance
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913935/
https://ncbi.nlm.nih.gov/pubmed/29378719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02327-17
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky